Table 4 Comparison of semen parameters in patients with LCS and non-LCS

Abstinence time (days), mean ± s.d

4.2 ± 2.0

4.3 ± 1.8

0.81

4.4 ± 2.0

4.2 ± 2.0

0.59

Semen volume (ml), median (Q1, Q3)

2.5

(1.7, 3.4)

2.9

(2.0, 4.0)

0.18

2.9

(2.1, 4.2)

3.1

(2.2, 4.1)

0.92

Semen volume < 1.5 (ml), n (%)

6 (16.7)

4 (7.7)

0.19

2 (5.7)

1 (1.4)

0.25*

Sperm concentration (×10⁶/ml), median (Q1, Q3)

53.8

(24.3, 101.4)

69.2

(28.8, 106.8)

0.61

83.8

(38.9, 133.2)

90.2

(55.4, 138.3)

0.55

Sperm concentration < 15 × 10⁶/ml, n (%)

4 (11.1)

6 (11.5)

0.95

2 (5.7)

8 (11.1)

0.49*

Progressive motility (%), median (Q1, Q3)

35.6

(19.9, 45.3)

31.5

(19.0, 45.1)

0.65

46.5

(25.4, 59.2)

40.0

(15.7, 54.4)

0.39

Progressive motility < 32 %, n (%)

14 (38.9)

27 (51.9)

0.23

10 (28.6)

27 (37.5)

0.36

Total motility (%), median (Q1, Q3)

41.2

(23.2, 55.2)

38.2

(22.5, 55.6)

0.72

51.7

(30.2, 63.9)

48.5

(19.4, 63.7)

0.63

Total motility < 40 %, n (%)

16 (44.4)

27 (51.9)

0.49

10 (28.6)

27 (37.5)

0.36

Normal morphology (%), median (Q1, Q3)

5.0

(3.0, 6.8)

5.0

(3.3, 7.0)

0.94

6.0

(4.0, 8.0)

5.0

(4.0, 8.0)

0.29

Normal morphology < 4 %, n (%)

10 (27.8)

13 (25.0)

0.77

8 (22.9)

16 (22.2)

0.94

Leukocytes (×10⁶/ml), median (Q1, Q3)

6.4

(3.0, 6.3)

4.2

(2.6, 7.0)

0.73

0.2

(0.1, 0.3)

0.2

(0.1, 0.3)

0.21